What are the potential side effects of TRX103?

This is a question you may want to discuss with your doctor regarding the Treatment of Moderate to Severe Refractory Crohn's Disease clinical trial (NCT06721962). Contact the study team or your healthcare provider for specific answers.

How does this treatment compare to other options I have tried?

This is a question you may want to discuss with your doctor regarding the Treatment of Moderate to Severe Refractory Crohn's Disease clinical trial (NCT06721962). Contact the study team or your healthcare provider for specific answers.

What will the treatment schedule look like, and how often will I need to visit the clinic?

This is a question you may want to discuss with your doctor regarding the Treatment of Moderate to Severe Refractory Crohn's Disease clinical trial (NCT06721962). Contact the study team or your healthcare provider for specific answers.

What criteria will determine if I am eligible for this trial?

This is a question you may want to discuss with your doctor regarding the Treatment of Moderate to Severe Refractory Crohn's Disease clinical trial (NCT06721962). Contact the study team or your healthcare provider for specific answers.

How will my progress be monitored during the study?

This is a question you may want to discuss with your doctor regarding the Treatment of Moderate to Severe Refractory Crohn's Disease clinical trial (NCT06721962). Contact the study team or your healthcare provider for specific answers.

What happens if I experience side effects or my condition worsens?

This is a question you may want to discuss with your doctor regarding the Treatment of Moderate to Severe Refractory Crohn's Disease clinical trial (NCT06721962). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

Treatment of Moderate to Severe Refractory Crohn's Disease

NCT0672196213 sitesClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Treatment of Moderate to Severe Refractory Crohn's Disease